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Summary
The data presented in this paper describe trends in treated problem drug use in 
Ireland between 2001 and 2006. The paper describes treated problem drug use in 
relation to person, place and time. The analysis presented is based on data reported to 
the National Drug Treatment Reporting System (NDTRS) and to the Central Treatment 
List (CTL). It is important to note that the NDTRS collects data on episodes of 
treatment, rather than the number of individual people treated each year. This means 
that individuals may appear in the figures more than once if they attend more than 
one treatment service in a year, and may reappear in subsequent years.
The main findings and their implications are:
There were 68,754 cases treated between 2001 and 2006, of which 31,620 • 
entered treatment during the six-year period. Of these cases, 29,373 (93%) 
lived in Ireland at an identified address, 2,203 (7%) lived in Ireland at an 
unidentified address and 44 (0.1%) did not live in Ireland.
In Ireland, treatment for problem drug use is provided in outpatient, inpatient, • 
low-threshold and general practice settings. Of the 68,754 cases treated 
between 2001 and 2006, the majority (68%) attended outpatient services. The 
number of individuals in methadone treatment from the preceding calendar 
year and carried forward on 1 January each year increased by 46%, from 
4,963 in 2001 to 7,269 in 2006. Just over 2,300 methadone treatment places 
have been created since the beginning of the current National Drugs Strategy 
(2001–2008).
Of the 5,191 cases entering treatment for problem drug use in 2006, 51% • 
received counselling, 39% received methadone substitution, 17% received a 
brief intervention and 14% attended medication-free therapy. Thirty-six per 
cent of cases received more than one initial treatment intervention. It is widely 
recognised that a combination of interventions is required to treat problem 
drug use effectively. In recent years there has been an increase in the types of 
intervention provided, and a greater emphasis on brief intervention, counselling, 
family therapy, aftercare and social re-integration. 
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The • prevalence of treated problem drug use among 15–64-year-olds living in Ireland, expressed 
per 100,000 of the population, increased by 15%, from 372 in 2001 to 426 in 2006. This increase 
consists mainly of previously treated cases, indicating that problem drug use is a chronic health 
condition that requires repeated episodes of treatment over time or continued treatment for an 
extended period of time. 
New cases entering treatment are an indirect indicator of recent trends in problem drug use. The • 
incidence of treated problem drug use among 15–64-year-olds living in Ireland was marginally 
lower in 2006 (74.8 cases per 100,000) than in 2001 (75.7 cases). 
The relatively stable incidence observed during the period masks separate trends in the former health • 
board areas. The number of new cases increased by 100% in the Western, by 57% in the Midland, 
by 37% in the North Eastern and by 33% in the Mid-Western health board areas between 2001 and 
2006. The number of new cases increased by 89% in the South Eastern Health Board area between 
2001 and 2005. 
An opiate (mainly heroin) was the most common main problem drug reported by new cases who • 
lived in Dublin. There was a 31% decrease in the number of new opiate cases who lived in Dublin, 
from 675 in 2001 to 468 in 2006, indicating that the heroin epidemic in this area has abated. In 
contrast, there was a 96% increase in the number of new opiate cases who lived outside Dublin, 
from 226 in 2001 to 442 in 2006. 
The main problem drugs reported by new cases were cannabis (41%), opiates (39%) and cocaine • 
(9%). In line with the results of the 2006/7 general population survey, the number of new cases who 
reported cocaine as their main problem drug increased noticeably, from 43 in 2001 to 342 in 2006. 
The number of new cases reporting cannabis as their main problem drug increased marginally. 
The most commonly reported main problem drug for new cases varied between HSE regions: cases • 
living in the Dublin North East and Dublin Mid-Leinster regions reported opiates, while cases living in 
the South and West regions reported cannabis. Across all HSE regions, between 7% and 10% of new 
cases reported cocaine as their main problem drug, which indicates that problem cocaine use is a 
small but nationwide problem.
The vast majority (72%) of new cases treated between 2001 and 2006 reported problem use of more • 
than one substance (polysubstance use). The proportion of new cases entering drug treatment who 
reported using more than one drug remained constant between 2004 and 2006. In the HSE South 
and West regions, the two most common additional problem drugs reported by new cases were 
alcohol and ecstasy. Cannabis and cocaine were the two most common additional problem drugs 
reported by new cases in the HSE Dublin North East and Dublin Mid-Leinster regions. Of the new 
cases who entered treatment during the period under review, 31% reported problem use of two 
substances, 23% reported problem use of three substances and 18% reported problem use of four 
or more substances. Polysubstance use increases the complexity of these cases, and is associated with 
poorer treatment outcomes. 
The association between the main problem drug and additional drugs among new cases entering • 
treatment was examined for the period 2001 to 2006. The pattern of additional drugs used was 
linked to the main problem drug. The additional substances used with cannabis and cocaine indicate 
their link with alcohol and other recreational drugs. Information about the combinations of drugs 
used and the situation in which they are used is important in terms of individual clients’ care plans, 
and policy initiatives.
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The rise in polysubstance use presents a challenge to drug treatment and monitoring systems that • 
have traditionally focused on the use of individual substances. While there are no policy links between 
alcohol and drug treatment services in Ireland, in practice, many drug services also treat clients with 
problem alcohol use. There appears to be a growing consensus in recent years that responses to 
problem drug and alcohol use should be integrated. The data presented in this paper indicate that 
there is a definite overlap between problem alcohol and other drug use, and highlight the need for 
an integrated approach to the management of substance misuse in this country. Indeed, a number of 
the former health boards have linked drug and alcohol treatment at local level.
In total, 2,473 new injector cases entered treatment between 2001 and 2006. Over half of these • 
were still injecting on entry to treatment, and 47% reported sharing injecting equipment. The 
proportion of injector cases who reported sharing equipment decreased from 51% in 2001 to 44% 
in 2006, which indicates the positive effect of proactive outreach work. The number of new cases 
entering treatment who had ever injected drugs was much lower in the HSE South and West regions 
than in the HSE Dublin Mid-Leinster and Dublin North East regions. Injecting drug use was associated 
with opiates and, to a lesser extent, with amphetamines and cocaine. Several studies in Ireland have 
linked injecting drug use with infection by blood-borne viruses such as hepatitis C and HIV.
In general, problem drug users are young and male, have low levels of education and are unlikely to • 
be employed, indicating the importance of personal development and educational and employment 
opportunities as part of the drug treatment and reintegration process. Almost 18% of all new cases 
treated were under 18 years of age, while just under 3% of treated previously cases were in this 
young age group.
Though small, the proportion of cases who reported being homeless and the proportion not born • 
in Ireland increased steadily during the reporting period. Previously treated cases entering treatment 
reported a higher incidence of homelessness (5%) than new cases entering treatment (3%). The 
proportion of cases who reported that they were not born in Ireland was higher among new cases 
(4%) than among previously treated cases (3%) in 2006. The increase in the proportion of other 
nationalities seeking treatment may have implications for service provision as drug treatment 
interventions rely heavily on verbal communication.
In 2004, there was a decrease in returns to the NDTRS from many areas of the country because • 
of a change in the NDTRS protocol and a lack of clarity about how the new protocol was to be 
applied at each treatment service. Completion of NDTRS forms or Dublin Addiction Information 
System (DAIS) entries by counsellors working in drug treatment centres in Dublin is sporadic and 
lower than desired. NDTRS returns were not completed by some services in the former Mid-Western 
Health Board area between 2002 and 2005, but this was rectified in 2006 and 2007. While there has 
been an improvement in NDTRS returns by general practitioners, further work is required to sustain 
this improvement and increase coverage. The proportion of new cases aged under 18 years was 
considerably higher in the HSE West and South regions than in the other two HSE regions; this may 
be due to under-reporting in the other two HSE regions or to a lack of appropriate treatment facilities 
for young drug users in those regions. The issues raised in this paragraph should be kept in mind 
when interpreting this paper.
4 HRB Trends Series 2
Glossary of terms
The median is the value at the mid–point in a sequence of numerical values ranged in ascending or • 
descending order. It is defined as the value above or below which half of the values lie. Unlike the 
mean (average), the median is not influenced by extreme values (or outliers). For example, in the 
case of five drug users aged 22, 23, 24, 24 and 46 years respectively, the median (middle value) is 
24 years, whereas the mean is 27.8 years. While both the median and the mean describe the central 
value of the data, the median is more useful in this case because the mean is influenced by the one 
older person in this example. 
Incidence is a term used to describe the number of new cases of disease or events that develop • 
among a population during a specified time interval. For example: in 2007, in a county with a 
population of 31,182, 10 opiate users sought treatment for the first time. The incidence is the 
number of new cases treated divided by the county population, expressed per given number of the 
population, i.e., per 100, per 1,000, per 10,000, per 100,000 etc. The rate in this example may be 
calculated as follows: (10/31,182) x 100,000, which gives an incidence rate of 32 per 100,000 of the 
county population in 2007. 
Prevalence is a term used to describe the proportion of people in a population who have a disease or • 
condition at a specific point or period in time. For example: in 2007, in a county with a population 
of 31,182, 10 opiate users sought treatment for the first time, 20 returned to treatment and five 
continued in treatment from the previous year, giving a total of 35 people treated for problem 
opiate use in the year. The prevalence is the total number of cases divided by the county population, 
expressed per given number of the population, i.e., per 100, per 1,000, per 10,000, per 100,000 
etc. The rate in this example may be calculated as follows: (35/31,182) x 100,000, which gives a 
prevalence rate of 112 per 100,000 of the county population in 2007.
Epidemic disease levels exist when there is an excess number of new cases among a specific • 
population for that point and place in time. An epidemic can also be called an outbreak. An excess 
number of cases is defined as a number greater than two standard deviations above the norm 
expected for that point in time. 
Health Service Executive (HSE) • 
On 1 January 2005, the 10 health boards managing the health services in Ireland were replaced  –
by a single entity, the Health Service Executive (HSE). The former health boards were responsible 
for health care provision to populations in specific geographical areas. In the interest of continuity 
of care, the HSE maintained these 10 areas for an interim period and called them HSE areas. The 
table below presents the past health board structure and the interim HSE area structure:
Regional Health Authority Health boards HSE areas
Not applicable North Eastern Health Board HSE North Eastern Area
Eastern Regional Health Authority (ERHA*) Northern Area Health Board HSE Northern Area
Eastern Regional Health Authority (ERHA) East Coast Area Health Board HSE East Coast Area
Eastern Regional Health Authority (ERHA) South Western Area Health Board HSE South Western Area
Not applicable Midland Health Board HSE Midland Area
Not applicable South Eastern Health Board HSE South Eastern Area
Not applicable Southern Health Board HSE Southern Area
Not applicable Mid–Western Health Board HSE Mid-Western Area
Not applicable North Western Health Board HSE North Western Area
Not applicable Western Health Board HSE Western Area
*The ERHA was known as the HSE Eastern Region for the interim period.
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Following a number of years of re-structuring, health care is now provided through four HSE  –
regions and 32 local health offices (LHOs). The local health offices are based on the geographical 
boundaries of the former community care areas. The table below presents the current HSE 
structure:
HSE regions Local health offices
HSE Dublin North East 
North West Dublin
North Central Dublin
North Dublin
Cavan/Monaghan
Louth
Meath
HSE Dublin Mid-Leinster 
Dun Laoghaire
Dublin South East
Dublin South City
Dublin South West
Dublin West
Kildare/West Wicklow
Wicklow
Longford/Westmeath
Laois/Offaly
HSE South 
Cork South Lee
Cork North Lee
West Cork
North Cork
Kerry
Carlow/Kilkenny
Tipperary South 
Waterford
Wexford
HSE West 
Donegal
Sligo/Leitrim/West Cavan
Galway
Mayo
Roscommon
Tipperary North/
East Limerick
Limerick
Clare
The data in this paper relating to the average annual incidence of treated problem drug use and  –
place of residence of treated cases living in Ireland are presented by HSE region and by former 
health board area. Each of the four HSE regions is made up of a number of former health board 
areas and can be easily divided along their boundaries. It is also worth noting that the 10 regional 
drugs task forces were created to service the areas covered by the former health boards.
Introduction
The National Drug Treatment Reporting System (NDTRS) is an epidemiological database on treated drug 
and alcohol misuse in Ireland. It is co-ordinated by staff at the Alcohol and Drug Research Unit (ADRU) 
of the Health Research Board (HRB) on behalf of the Department of Health and Children. The monitoring 
role of the NDTRS is recognised by the Government in its document Building on experience: National Drugs 
Strategy 2001–2008. The collection and reporting of data to the NDTRS is one of the actions identified and 
agreed by Government for implementation by the former health boards (now HSE regions): ‘All treatment 
providers should co-operate in returning information on problem drug use to the Drug Misuse Research 
Division [now ADRU] of the HRB’ (Department of Tourism, Sport and Recreation 2001: 118). 
The NDTRS was established in 1990 in the Greater Dublin Area and was extended in 1995 to cover all 
areas of the country. It was developed in line with the Pompidou Group’s Definitive Protocol (Hartnoll 
1994) and subsequently refined in accordance with the Treatment Demand Indicator Protocol (EMCDDA 
and Pompidou Group 2000). Originally designed to record drug misuse, the NDTRS recorded problematic 
use of alcohol only in cases where it was an additional problem substance, that is, where the client’s main 
reason for entering treatment was drug misuse but he/she also reported problematic use of alcohol.
However, it became increasingly evident that alcohol was the main problem substance in Ireland and 
that a large proportion of cases used both alcohol and drugs (Long et al. 2004). In parts of the country, 
particularly outside Dublin, alcohol and drug treatment services are integrated. Failure to include alcohol 
data in reporting systems leads to an underestimation of problem substance use, and of the workload of 
addiction services (Long et al. 2004). In recognition of this, the remit of the NDTRS was extended in 2004 
to include cases where alcohol is recorded as the main or only reason for seeking treatment. The overlap 
between problem alcohol and drug use has been identified in the current strategic plans of a number of 
drugs task forces, which have emphasised the need for treatment services that can address the many forms 
of polysubstance use.
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Drug and alcohol treatment data are viewed as an indirect indicator of drug and alcohol misuse as well 
as a direct indicator of demand for treatment services. NDTRS data are used at national level (alcohol 
and drug data) and at European level (drug data) to provide information on the characteristics of clients 
entering treatment and on patterns of substance misuse, such as types of substance used and consumption 
behaviours. Drug data are ‘valuable from a public health perspective to assess needs, …and to plan and 
evaluate services’ (EMCDDA 1998: 23). 
Information from the NDTRS is made available to service providers and policy makers and is used to inform 
local and national substance misuse policy and planning. In 1996, NDTRS data were used to identify a 
number of local areas with problematic heroin use (Ministerial Task Force 1996). These areas were later 
designated as Local Drugs Task Force (LDTF) areas, and are continuing to co-ordinate strategic responses 
to drug misuse in their communities. Again, in 2004, NDTRS data were used to describe treatment-seeking 
characteristics and behaviours of those under 18 years and to inform the deliberations of the Working 
Group on the need for a specific treatment approach (Working Group on treatment of under 18 year 
olds 2005). In recent years, NDTRS data have been used to inform some of the recommendations of the 
Working Group on Drugs Rehabilitation (2007), and by the Working Group on residential services to help 
estimate the number of residential places required to address severe alcohol and drug problems in Ireland 
(Corrigan and O’Gorman 2007). 
The National Advisory Committee on Drugs (NACD) and the Department of Health, Social Services and 
Public Safety (Northern Ireland) published jointly two all-Ireland general population drug prevalence surveys 
which provide another view of drug use in Ireland (NACD and DAIRU 2005, 2008). The proportion of 
adults (aged 15–64 years) who reported using an illegal drug in their lifetime increased by 5 percentage 
points, from 19% in 2002/3 to 24% in 2006/7. The proportion of young adults (aged 15–34 years) who 
reported using an illegal drug in their lifetime also increased by 5 percentage points, from 26% in 2002/3 
to 31% in 2006/7. As expected, more men than women reported using an illegal drug in their lifetime. 
The proportion of adults who reported using an illegal drug in the last year increased marginally, from 6% 
in 2002/3 to 7% in 2006/7. The proportion of young adults who reported using an illegal drug in the last 
year increased from 10% in 2002/3 to 12% in 2006/7. The proportion of adults who reported using an 
illegal drug in the last month remained stable at 3% in the two surveys.
Cannabis was the most commonly used illegal drug in Ireland. The proportion of adults who reported 
using cannabis at some point in their life increased from 17% in 2002/3 to 22% in 2006/7. Just over 5% 
of adults claimed to have tried ecstasy at least once in their lifetime in 2006/7. The proportion of adults 
who reported using cocaine (including crack) at some point in their life increased from 3% in 2002/3 to 
5% in 2006/7. The proportion of young adults who reported using cocaine in their lifetime also increased, 
from 5% in 2002/3 to 8% in 2006/7. As expected, more men than women reported using cocaine in their 
lifetime. The proportion of adults who reported using cocaine in the last year increased from 1% in 2002/3 
to almost 2% in 2006/7. The proportion of young adults who reported using cocaine in the last year 
increased from 2% in 2002/3 to 3% in 2006/7. The proportion of adults who reported using cocaine in the 
last month was similar in both surveys at less than 1%.
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Methods
Treatment for problem drug use in Ireland is provided by statutory and non-statutory services, including 
residential centres, community-based addiction services, general practices and prison services. 
For the purpose of the NDTRS, treatment is broadly defined as any activity which aims to ameliorate the 
psychological, medical or social state of individuals who seek help for their substance misuse problems. 
Clients who attend needle-exchange services are not included in this reporting system. From 2004 
onwards, clients who report alcohol as their main problem drug have been recorded by the system. 
These data have been presented in an earlier paper in the HRB Trends Series (Fanagan et al. 2008). Drug 
treatment options include one or more of the following: medication (detoxification, methadone reduction, 
substitution programmes and psychiatric treatment), brief intervention, counselling, group therapy, family 
therapy, psychotherapy, complementary therapy, and/or life-skills training.
Compliance with the NDTRS requires that one form be completed for each new client coming for first 
treatment and for each previously treated client returning to treatment for problem drug use. Service 
providers at treatment centres throughout Ireland collect data on each individual who attends for first 
treatment or returns to treatment in a calendar year. In February each year, staff maintaining the Central 
Treatment List provide the HRB with data on the number of individuals who were receiving methadone 
treatment on 31 December in the preceding year and carried forward to 1 January in the current year. The 
Central Treatment List (CTL) was established under Statutory Instrument No. 225. This list is administered 
by the Drug Treatment Centre Board on behalf of the Health Service Executive and is a complete register of 
all clients receiving methadone as treatment for problem opiate use in Ireland. When a person is considered 
suitable for methadone detoxification or maintenance, the prescribing doctor applies to the CTL for a place, 
and a unique number is allocated to the client. Under this system, each client can receive their methadone 
from one source only.
Staff at the ADRU of the HRB compile anonymous, aggregated data, which are analysed and reported at 
national and EU levels.
The main elements of the reporting system are defined as follows: 
All cases treated – describes individuals who receive treatment for problem drug and/or alcohol use at each 
treatment centre in a calendar year, and includes: 
Continuous care cases – describes individuals continuing in methadone treatment from the preceding 
calendar year and carried forward to 1 January each year;
Previously treated cases – describes individuals who were treated previously for problem drug use at any 
treatment centre and have returned to treatment in the reporting year; 
New cases treated – describes individuals who have never been treated for problem drug use; and
Status unknown – describes individuals whose status with respect to previous treatment for problem drug 
use is not known.
In the case of the data for ‘previously treated cases’, there is a possibility that individuals appear more than 
once in the database: for example, where a person receives treatment at more than one centre. 
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Treatment is provided in both residential and non-residential settings (Table 1). Data returns to the NDTRS 
for clients entering treatment services for problem drug use during 2006 were provided by 238 treatment 
services, comprising 146 outpatient services, 23 residential facilities, three low-threshold services and 66 
general practitioners. 
The data presented in this paper provide a description of problem drug use in Ireland by health area 
of residence between 2001 and 2006. There were 68,754 cases treated in the six-year period, of which 
31,620 entered treatment during the reporting period. Of these cases, 29,373 (93%) lived in Ireland at 
an identified address, 2,203 (7%) lived in Ireland at an unidentified address and 44 (0.1%) did not live in 
Ireland. The tables presenting data on service provision and treatment status are based on the total number 
of 68,754 treated cases (Tables 1 and 2). Table 3 presents data on the 31,620 cases who entered treatment 
during the period under review. The remainder of the tables are based on the 29,373 cases who entered 
treatment and whose HSE region of residence in Ireland was known. 
Analysis
The analysis presented demonstrates the public health importance of problem drug use and provides an 
outline of the following: service provision; numbers treated; incidence and prevalence of treatment; main 
problem drugs; additional problem drugs; initial treatment intervention(s) provided; risk behaviours; socio-
demographic characteristics; and relationships between the main problem drug and selected characteristics. 
Service provision
The total number of drug treatment services available in Ireland and participating in the NDTRS increased 
between 2001 and 2006 (Table 1). The largest increase was in outpatient treatment services. Of the 68,754 
cases treated, the majority (68%) attended outpatient services. The Prison Service has not participated in 
the NDTRS up to now, but intends to submit data from 2008 onwards. The number of general practitioners 
providing data to the NDTRS decreased sharply, from 99 in 2005 to 66 in 2006. This could be due to a lapse 
in participation or a decrease in cases entering treatment; this observation requires further investigation.
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Table 1 Number and types of service providing treatment for problem drug use and number of 
cases in treatment (in brackets) in Ireland and reported to the NDTRS or the CTL, 2001 
to 2006 
Type of service 2001 2002 2003 2004 2005 2006
Number of services (Number of cases treated)
All cases in treatment (10098) (11062) (11515) (11235) (12100) (12744)
Outpatient N/A (7134) N/A (7723) N/A (7808) N/A (7487) N/A (8156) N/A (8626)
Residential N/A (725) N/A (800) N/A (900) N/A (739) N/A (827) N/A (994)
Low-threshold* N/A (227) N/A (188) N/A (269) N/A (310) N/A (289) N/A (234)
General practitioner N/A (2012) N/A (2343) N/A (2527) N/A (2699) N/A (2828) N/A (2890)
Service type unknown† N/A (0) N/A (8) N/A (11) N/A (0) N/A (0) N/A (0)
Cases continuing in 
methadone treatment 
from previous year‡
(4963) (5601) (5944) (6433) (6924) (7269)
Outpatient N/A (3239) N/A (3652) 77 (3758) 77 (4044) 79 (4328) 81 (4532)
Residential N/A (7) N/A (11) 2 (9) 2 (8) 4 (10) 2 (7)
Low-threshold* N/A (87) N/A (63) 2 (64) 2 (89) 2 (98) 2 (88)
General practitioner N/A (1630) N/A (1875) 207 (2113) 221 (2292) 224 (2488) 230 (2642)
Service type unknown† 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Previously treated and new 
cases who entered treatment 
during year
(5135) (5461) (5571) (4802) (5176) (5475)
Outpatient 117 (3895) 121 (4071) 132 (4050) 144 (3443) 146 (3828) 146 (4094)
Residential 16 (718) 20 (789) 17 (891) 19 (731) 21 (817) 23 (987)
Low-threshold* 2 (140) 2 (125) 3 (205) 3 (221) 3 (191) 3 (146)
General practitioner 83 (382) 92 (468) 91 (414) 95 (407) 99 (340) 66 (248)
Service type unknown† 0 (0) 1 (8) 1 (11) 0 (0) 0 (0) 0 (0)
*Low-threshold services are services that provide low-dose methadone or drop-in facilities only.
† Relevant data not recorded on the NDTRS form returned.
‡ Data provided by the Central Treatment List. 
Numbers treated
Of the 68,754 cases in treatment for problem drug use between 2001 and 2006, 37,134 (54%) were 
continuous care cases. Continuous care cases are those continuing in methadone treatment from the 
preceding calendar year and carried forward on 1 January each year. The number of cases carried forward 
increased by 46%, from 4,963 in 2001 to 7,269 in 2006 (Table 1). Just over 2,300 methadone places 
have been created since the beginning of the National Drugs Strategy in 2001. The number of previously 
treated cases increased by 6%, from 2,837 in 2001 to 3,000 in 2006 (Table 2). Continuous care cases and 
previously treated cases are an indicator of a chronic situation and the requirement for addiction services 
into the future. The number of new cases increased by 8%, from 2,108 in 2001 to 2,278 in 2006. New 
cases entering treatment are an indirect indicator of recent trends in problem drug use.
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Table 2 Number (%) of cases in treatment in Ireland, by treatment status, reported to the NDTRS, 
2001 to 2006
Treatment status 2001 2002 2003 2004 2005 2006
Number (%)
All cases in treatment 10098 11062 11515 11235 12100 12744
Cases continuing in methadone 
treatment from previous year
4963 (49.1) 5601 (50.6) 5944 (51.6) 6433 (57.3) 6924 (57.2) 7269 (57.0)
Entries to treatment each year 5135 5461 5571 4802 5176 5475
Of which:
Previously treated cases returning 
to treatment
2837 (28.1) 3072 (27.8) 3192 (27.7) 2765 (24.6) 2970 (24.5) 3000 (23.5)
New cases 2108 (20.9) 2131 (19.3) 2245 (19.5) 1858 (16.5) 2054 (17.0) 2278 (17.9)
Treatment status unknown* 190 (1.9) 258 (2.3) 134 (1.2) 179 (1.6) 152 (1.3) 197 (1.5)
*Relevant data not recorded on the NDTRS form returned.
Of the 31,620 cases entering treatment for problem drug use, 29,373 (93%) lived in Ireland at an 
identified address, 2,203 (7%) lived in Ireland at an unidentified address and 44 (0.1%) did not live in 
Ireland (Table 3). 
The remainder of the tabular analysis in this paper is based on 29,373 cases who lived in one of the four 
HSE regions and entered treatment for problem drug use in Ireland between 2001 and 2006. 
Table 3 Number (%) of cases entering treatment in Ireland, by place of residence, reported to the 
NDTRS, 2001 to 2006
Place of residence 2001 2002 2003 2004 2005 2006
Number (%)
All cases entering treatment 5135 5461 5571 4802 5176 5475
Specified HSE region 4797 (93.4) 4948 (90.6) 5054 (90.7) 4506 (93.8) 4877 (94.2) 5191 (94.8)
Ireland unknown 331 (6.4) 504 (9.2) 514 (9.2) 291 (6.1) 290 (5.6) 273 (5.0)
Not resident in Ireland 7 (0.1) 9 (0.2) 3 (0.1) 5 (0.1) 9 (0.2) 11 (0.2)
In 2004, the total number of cases entering treatment decreased in all HSE regions apart from HSE Dublin 
Mid-Leinster, but in the following years the number of cases gradually increased in all HSE regions (Table 
4). The NDTRS protocol changed in 2004; this may have reduced compliance in some HSE regions, which 
may explain the decrease in numbers in 2004. In the six-year period as a whole, the highest proportion 
of all cases entering drug treatment lived in HSE Dublin Mid-Leinster Region (39%); 29% lived in the HSE 
Dublin North East Region; and the lowest proportion (10%) lived in HSE West Region (Table 4). The highest 
proportion of new cases entering drug treatment lived in the HSE South Region (34%); 27% lived in the 
HSE Dublin Mid-Leinster Region; and the lowest proportion (14%) lived in the HSE West Region. The largest 
proportional increase in new cases between 2001 and 2006 was in the HSE West Region (at 35%), followed 
by the HSE Dublin North East (at 18%) and South (at 11%) regions.
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Table 4 Number (%) of cases entering treatment in Ireland, by HSE region of residence and by 
treatment status, reported to the NDTRS, 2001 to 2006
HSE region 
of residence*
2001 2002 2003 2004 2005 2006
Number (%)
All cases entering 
treatment
4797 4948 5054 4506 4877 5191
Dublin North East 1446 (30.1) 1278 (25.8) 1499 (29.7) 1347 (29.9) 1484 (30.4) 1511 (29.1)
Dublin Mid-Leinster 1966 (41.0) 2030 (41.0) 1802 (35.7) 1870 (41.5) 1876 (38.5) 1995 (38.4)
South 975 (20.3) 1144 (23.1) 1255 (24.8) 886 (19.7) 1047 (21.5) 1104 (21.3)
West 410 (8.5) 496 (10.0) 498 (9.9) 403 (8.9) 470 (9.6) 581 (11.2)
Previously treated 
cases
2588 2721 2838 2555 2760 2781
Dublin North East 859 (33.2) 771 (28.3) 963 (33.9) 850 (33.3) 942 (34.1) 811 (29.2)
Dublin Mid-Leinster 1281 (49.5) 1422 (52.3) 1238 (43.6) 1303 (51.0) 1331 (48.2) 1346 (48.4)
South 320 (12.4) 370 (13.6) 470 (16.6) 281 (11.0) 334 (12.1) 388 (14.0)
West 128 (4.9) 158 (5.8) 167 (5.9) 121 (4.7) 153 (5.5) 236 (8.5)
New cases 2030 2005 2097 1790 1976 2228
Dublin North East 531 (26.2) 444 (22.1) 499 (23.8) 442 (24.7) 488 (24.7) 629 (28.2)
Dublin Mid-Leinster 621 (30.6) 513 (25.6) 517 (24.7) 503 (28.1) 489 (24.7) 567 (25.4)
South 630 (31.0) 741 (37.0) 774 (36.9) 588 (32.8) 700 (35.4) 698 (31.3)
West 248 (12.2) 307 (15.3) 307 (14.6) 257 (14.4) 299 (15.1) 334 (15.0)
Treatment status 
unknown
179 222 119 161 141 182
*Excludes cases whose HSE region of residence is not known and cases not normally resident in Ireland.
Data are presented by former health board area of residence as these areas have the same geographical 
boundaries as seven of the 10 regional drugs task force areas, which is very useful for service planning 
purposes. The former South Western Area (of Dublin and Wicklow), Northern Area (of Dublin) and Southern 
health boards reported the highest numbers of cases entering treatment. The former North Western and 
Western health board areas reported the lowest numbers of cases entering treatment (Table 5). Apart 
from the South Western Area, all health board areas had a decrease in the total number of cases entering 
treatment in 2004. The total number of cases who entered treatment in the South Western Area decreased 
by 17% between 2001 and 2003 and increased again in 2004. The total number of cases entering 
treatment in the Western Health Board area increased by 144% between 2001 and 2006. 
In the Southern, North Western, Midland, Western and South Eastern health board areas the numbers of 
previously treated cases increased between 2001 and 2003 but decreased in 2004. The small numbers of 
previously treated cases entering treatment and living in the Mid-Western Health Board area decreased 
between 2002 and 2004. This decrease is likely to be explained by under-reporting to the NDTRS, rather 
than by a true decrease in problematic drug use or a decrease in service provision; the figure increased by 
108% between 2004 and 2006.
New cases entering treatment are an indirect indicator of recent trends in problem drug use. The number 
of new treated cases living in the East Coast Area Health Board (of Dublin and Wicklow) decreased by 63%, 
from 144 in 2001 to 54 in 2005, and increased noticeably (to 95 cases) in 2006. The number of new cases 
entering treatment and living in the South Western Area Health Board decreased by 36% between 2001 
and 2003, increased again in 2004, and remained relatively stable in the following two years. Opiates 
(mainly heroin) were the main drugs reported by cases who attended drug treatment centres in Dublin, 
and the stabilisation in the number of new cases is an indicator that the opiate epidemic in Dublin in the 
nineties has abated. 
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Table 5 Number (%) of cases entering treatment in Ireland, by former health board area of 
residence and by treatment status, reported to the NDTRS, 2001 to 2006
Former health board area 
of residence*
2001 2002 2003 2004 2005 2006
Number (%)
All cases entering 
treatment
4797 4948 5054 4506 4877 5191
Southern 616 (12.8) 660 (13.3) 645 (12.8) 378 (8.4) 490 (10.0) 513 (9.9)
North Western 101 (2.1) 110 (2.2) 120 (2.4) 118 (2.6) 108 (2.2) 102 (2.0)
Midland 117 (2.4) 148 (3.0) 228 (4.5) 196 (4.3) 175 (3.6) 195 (3.8)
Western 79 (1.6) 144 (2.9) 160 (3.2) 105 (2.3) 178 (3.6) 193 (3.7)
Mid-Western 230 (4.8) 242 (4.9) 218 (4.3) 180 (4.0) 184 (3.8) 286 (5.5)
North Eastern 370 (7.7) 306 (6.2) 387 (7.7) 374 (8.3) 365 (7.5) 471 (9.1)
South Eastern 359 (7.5) 484 (9.8) 610 (12.1) 529 (11.7) 609 (12.5) 636 (12.3)
East Coast Area 332 (6.9) 391 (7.9) 304 (6.0) 230 (5.1) 260 (5.3) 327 (6.3)
South Western Area 1464 (30.5) 1426 (2.8) 1215 (24.0) 1392 (30.9) 1364 (28.0) 1414 (27.2)
Northern Area (Dublin) 1076 (22.4) 972 (19.6) 1112 (22.0) 97321.6 1119 (22.9) 1040 (20.0)
Area of residence unknown† 53 (1.1) 65 (1.3) 55 (1.1) 31 (0.7) 25 (0.5) 14 (0.3)
Previously treated cases 2588 2721 2838 2555 2760 2781
Southern 195 (7.5) 214 (7.9) 267 (9.4) 108 (4.2) 165 (6.0) 165 (5.9)
North Western 28 (1.1) 36 (1.3) 40 (1.4) 29 (1.1) 22 (.8) 33 (1.2)
Midland 42 (1.6) 57 (2.1) 91 (3.2) 82 (3.2) 66 (2.4) 77 (2.8)
Western 31 (1.2) 46 (1.7) 62 (2.2) 43 (1.7) 75 (2.7) 101 (3.6)
Mid-Western 69 (2.7) 76 (2.8) 65 (2.3) 49 (1.9) 56 (2.0) 102 (3.7)
North Eastern 125 (4.8) 99 (3.6) 146 (5.1) 130 (5.1) 125 (4.5) 149 (5.4)
South Eastern 125 (4.8) 156 (5.7) 203 (7.2) 178 (7.0) 183 (6.6) 242 (8.7)
East Coast Area 179 (6.9) 236 (8.7) 197 (6.9) 161 (6.3) 199 (7.2) 217 (7.8)
South Western Area 1037 (40.1) 1088 (40.0) 928 (32.7) 1043 (40.8) 1041 (37.7) 1027 (36.9)
Northern Area (Dublin) 734 (28.4) 672 (24.7) 817 (28.8) 720 (28.2) 817 (29.6) 662 (23.8)
Area of residence unknown† 23 (0.9) 41 (1.5) 22 (0.8) 12 (0.5) 11 (0.4) 6 (0.2)
New cases 2030 2005 2097 1790 1976 2228
Southern 408 (20.1) 427 (21.3) 373 (17.8) 257 (14.4) 317 (16.0) 332 (14.9)
North Western 71 (3.5) 71 (3.5) 75 (3.6) 86 (4.8) 79 (4.0) 68 (3.1)
Midland 74 (3.6) 70 (3.5) 135 (6.4) 107 (6.0) 105 (5.3) 116 (5.2)
Western 46 (2.3) 91 (4.5) 94 (4.5) 59 (3.3) 97 (4.9) 92 (4.1)
Mid-Western 131 (6.5) 145 (7.2) 138 (6.6) 112 (6.3) 123 (6.2) 174 (7.8)
North Eastern 221 (10.9) 186 (9.3) 229 (10.9) 236 (13.2) 224 (11.3) 303 (13.6)
South Eastern 222 (10.9) 314 (15.7) 401 (19.1) 347 (19.4) 420 (21.3) 392 (17.6)
East Coast Area  144 (7.1) 138 (6.9) 101 (4.8) 63 (3.5) 54 (2.7) 95 (4.3)
South Western Area 376 (18.5) 282 (14.1) 250 (11.9) 300 (16.8) 279 (14.1) 322 (14.5)
Northern Area (Dublin) 310 (15.3) 258 (12.9) 270 (12.9) 206 (11.5) 264 (13.4) 326 (14.6)
Area of residence unknown† 27 (1.3) 23 (1.1) 31 (1.5) 17 (0.9) 14 (0.7) 8 (0.4)
Treatment status unknown 179 222 119 161 141 182
*Excludes cases whose HSE region of residence is not known and cases who are not normally resident in Ireland.
†Refers to cases living in Wicklow who were not assigned a specific electoral division code; it is not possible to assign such cases to a 
former health board area of residence.
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The number of new cases living in the Southern Health Board area decreased by 19% over the reporting 
period, while the number of new cases in the North Western Health Board area decreased by 21% between 
2004 and 2006. The number of new cases living in the following areas increased between 2001 and 2006: 
Western (by 100%), Midland (by 57%), North Eastern (by 37%) and Mid-Western (by 33%). The number 
of new cases increased by 89% in the South Eastern Health Board area between 2001 and 2005. These 
increases are largely explained by an expansion in treatment services for problem drug use outside the 
Dublin area during the reporting period. 
With respect to local health office (LHO) areas, the total numbers of cases entering drug treatment between 
2001 and 2006 were highest for those living in Cork, Dublin South West, Dublin North Central and Dublin 
South City, and lowest for those living in Mayo and Roscommon (Table 6). 
The highest numbers of previously treated cases entering drug treatment between 2001 and 2006 lived in 
Dublin West, Dublin South West, Dublin North Central and Dublin South City LHO areas. 
The numbers of new cases who entered drug treatment and lived in the LHO areas of Kildare–West 
Wicklow, Galway, North Tipperary, Louth, Meath, Wexford and Waterford increased between 2001 
and 2006, while the numbers of new cases who entered treatment and lived in Laois–Offaly and South 
Tipperary increased in the earlier years under review but decreased in the later years. For example, the 
number of new cases entering treatment and living in the Laois–Offaly LHO area increased by almost 168% 
between 2001 and 2003 but decreased by 45% between 2003 and 2006. 
The numbers of new cases who entered treatment and lived in the LHO areas of Dublin North Central, 
Donegal, Sligo–Leitrim, Mayo, Roscommon and Carlow–Kilkenny remained stable during the reporting 
period. The numbers of new cases who entered treatment and lived in Dublin South City, Dublin South 
West, Dublin West and Kerry decreased between 2001 and 2006. For example, the number of new cases 
entering treatment and living in Dublin South City LHO area decreased by 38% during the reporting period. 
The numbers of new cases who entered treatment and lived in Dublin South, Dublin South East, North 
West Dublin, Dublin North Central, Wicklow East, Limerick, Cavan–Monaghan, Clare, and Longford–
Westmeath decreased in the earlier years under review, but increased in the later years. For example, the 
number of new cases living in Wicklow East LHO area decreased by 65% between 2001 and 2005 and 
increased by 37% in 2006. 
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Table 6 Number (%) of cases entering treatment in Ireland, by local health office (LHO) area of 
residence and by treatment status, reported to the NDTRS, 2001 to 2006
Local health office 2001 2002 2003 2004 2005 2006
Number (%)
All cases 4797 4948 5054 4506 4877 5191
Dublin South 135 (2.8) 193 (3.9) 137 (2.7) 70 (1.6) 87 (1.8) 118 (2.3)
Dublin South East 94 (2.0) 92 (1.9) 69 (1.4) 64 (1.4) 60 (1.2) 68 (1.3)
Dublin South City 387 (8.1) 445 (9.0) 373 (7.4) 362 (8.0) 344 (7.1) 318 (6.1)
Dublin South West 478 (10.0) 447 (9.0) 360 (7.1) 420 (9.3) 422 (8.7) 482 (9.3)
Dublin West 560 (11.7) 524 (10.6) 488 (9.7) 546 (12.1) 531 (10.9) 477 (9.2)
North West Dublin 371 (7.7) 356 (7.2) 389 (7.7) 307 (6.8) 326 (6.7) 352 (6.8)
Dublin North Central 427 (8.9) 354 (7.2) 447 (8.8) 382 (8.5) 524 (10.7) 414 (8.0)
North Dublin 264 (5.5) 261 (5.3) 271 (5.4) 284 (6.3) 266 (5.5) 272 (5.2)
Kildare–West Wicklow 90 (1.9) 73 (1.5) 68 (1.3) 109 (2.4) 109 (2.2) 177 (3.4)
Wicklow East 92 (1.9) 70 (1.4) 65 (1.3) 68 (1.5) 89 (1.8) 113 (2.2)
Kerry 84 (1.8) 102 (2.1) 113 (2.2) 39 (0.9) 69 (1.4) 63 (1.2)
Donegal 49 (1.0) 59 (1.2) 51 (1.0) 76 (1.7) 53 (1.1) 56 (1.1)
Sligo–Leitrim 52 (1.1) 51 (1.0) 69 (1.4) 42 (0.9) 55 (1.1) 46 (0.9)
Longford–Westmeath 75 (1.6) 77 (1.6) 105 (2.1) 89 (2.0) 66 (1.4) 119 (2.3)
Laois–Offaly 42 (0.9) 71 (1.4) 123 (2.4) 107 (2.4) 109 (2.2) 76 (1.5)
Galway 38 (0.8) 87 (1.8) 90 (1.8) 69 (1.5) 115 (2.4) 124 (2.4)
Mayo 34 (0.7) 24 (0.5) 31 (0.6) 20 (0.4) 41 (0.8) 35 (0.7)
Roscommon 7 (0.1) 33 (0.7) 39 (0.8) 16 (0.4) 22 (0.5) 34 (0.7)
Limerick 159 (3.3) 143 (2.9) 113 (2.2) 105 (2.3) 111 (2.3) 172 (3.3)
Clare 44 (0.9) 63 (1.3) 52 (1.0) 42 (0.9) 37 (0.8) 67 (1.3)
North Tipp–East Limerick 27 (0.6) 34 (0.7) 44 (0.9) 33 (0.7) 35 (0.7) 47 (0.9)
Louth 175 (3.6) 117 (2.4) 229 (4.5) 179 (4.0) 205 (4.2) 220 (4.2)
Meath 122 (2.5) 150 (3.0) 127 (2.5) 159 (3.5) 113 (2.3) 175 (3.4)
Cavan–Monaghan 73 (1.5) 39 (0.8) 31 (0.6) 36 (0.8) 47 (1.0) 74 (1.4)
Carlow–Kilkenny 136 (2.8) 185 (3.7) 145 (2.9) 157 (3.5) 168 (3.4) 159 (3.1)
South Tipperary 61 (1.3) 76 (1.5) 154 (3.0) 96 (2.1) 78 (1.6) 86 (1.7)
Wexford 68 (1.4) 107 (2.2) 149 (2.9) 131 (2.9) 185 (3.8) 203 (3.9)
Waterford 94 (2.0) 111 (2.2) 162 (3.2) 145 (3.2) 178 (3.6) 188 (3.6)
Cork† 532 (11.1) 555 (11.2) 531 (10.5) 338 (7.5) 421 (8.6) 445 (8.6)
LHO area unknown‡ 27 (0.6) 49 (1.0) 29 (0.6) 15 (0.3) 11 (0.2) 11 (0.2)
Previously treated cases 2588 2721 2838 2555 2760 2781
Dublin South 76 (2.9) 116 (4.3) 87 (3.1) 49 (1.9) 65 (2.4) 83 (3.0)
Dublin South East 61 (2.4) 55 (2.0) 47 (1.7) 48 (1.9) 47 (1.7) 35 (1.3)
Dublin South City 282 (10.9) 344 (12.6) 281 (9.9) 295 (11.5) 286 (10.4) 247 (8.9)
Dublin South West 358 (13.8) 338 (12.4) 286 (10.1) 307 (12.0) 315 (11.4) 369 (13.3)
Dublin West 381 (14.7) 405 (14.9) 376 (13.2) 422 (16.5) 427 (15.5) 363 (13.1)
North West Dublin 261 (10.1) 234 (8.6) 277 (9.8) 217 (8.5) 246 (8.9) 241 (8.7)
Dublin North Central 291 (11.2) 263 (9.7) 355 (12.5) 308 (12.1) 396 (14.3) 246 (8.8)
North Dublin 171 (6.6) 174 (6.4) 181 (6.4) 195 (7.6) 172 (6.2) 174 (6.3)
Kildare–West Wicklow 41 (1.6) 38 (1.4) 29 (1.0) 46 (1.8) 40 (1.4) 75 (2.7)
Wicklow East 35 (1.4) 41 (1.5) 37 (1.3) 43 (1.7) 68 (2.5) 77 (2.8)
Kerry 28 (1.1) 39 (1.4) 57 (2.0) 10 (0.4) 27 (1.0) 17 (0.6)
Donegal 16 (0.6) 15 (0.6) 9 (0.3) 12 (0.5) 8 (0.3) 19 (0.7)
Sligo–Leitrim 12 (0.5) 21 (0.8) 31 (1.1) 17 (0.7) 14 (0.5) 14 (0.5)
Longford–Westmeath 31 (1.2) 36 (1.3) 51 (1.8) 44 (1.7) 33 (1.2) 47 (1.7)
Laois–Offaly 11 (0.4) 21 (0.8) 40 (1.4) 38 (1.5) 33 (1.2) 30 (1.1)
Galway 15 (0.6) 28 (1.0) 37 (1.3) 31 (1.2) 52 (1.9) 69 (2.5)
Mayo 12 (0.5) 5 (0.2) 9 (0.3) 6 (0.2) 14 (0.5) 16 (0.6)
Roscommon 4 (0.2) 13 (0.5) 16 (0.6) 6 (0.2) 9 (0.3) 16 (0.6)
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Local health office 2001 2002 2003 2004 2005 2006
Number (%)
Previously treated cases 2588 2721 2838 2555 2760 2781
Limerick 41 (1.6) 36 (1.3) 31 (1.1) 23 (0.9) 36 (1.3) 58 (2.1)
Clare 19 (0.7) 25 (0.9) 17 (0.6) 14 (0.5) 9 (0.3) 25 (0.9)
North Tipp–East Limerick 9 (0.3) 14 (0.5) 13 (0.5) 12 (0.5) 11 (0.4) 19 (0.7)
Louth 69 (2.7) 38 (1.4) 101 (3.6) 53 (2.1) 79 (2.9) 70 (2.5)
Meath 33 (1.3) 52 (1.9) 34 (1.2) 64 (2.5) 32 (1.2) 59 (2.1)
Cavan–Monaghan 23 (0.9) 9 (0.3) 11 (0.4) 13 (0.5) 14 (0.5) 19 (0.7)
Carlow–Kilkenny 46 (1.8) 62 (2.3) 57 (2.0) 70 (2.7) 59 (2.1) 74 (2.7)
South Tipperary 20 (0.8) 16 (0.6) 42 (1.5) 30 (1.2) 23 (0.8) 30 (1.1)
Wexford 39 (1.5) 46 (1.7) 57 (2.0) 39 (1.5) 55 (2.0) 70 (2.5)
Waterford 20 (0.8) 30 (1.1) 47 (1.7) 39 (1.5) 46 (1.7) 68 (2.4)
Cork† 167 (6.5) 175 (6.4) 209 (7.4) 98 (3.8) 138 (5.0) 145 (5.2)
LHO area unknown‡ 16 (0.6) 32 (1.2) 13 (0.5) 6 (0.2) 6 (0.2) 6 (0.2)
New cases 2030 2005 2097 1790 1976 2228
Dublin South 54 (2.7) 69 (3.4) 45 (2.1) 19 (1.1) 19 (1.0) 33 (1.5)
Dublin South East 33 (1.6) 34 (1.7) 22 (1.0) 16 (0.9) 12 (0.6) 30 (1.3)
Dublin South City 91 (4.5) 84 (4.2) 77 (3.7) 60 (3.4) 53 (2.7) 56 (2.5)
Dublin South West 102 (5.0) 87 (4.3) 66 (3.1) 92 (5.1) 93 (4.7) 93 (4.2)
Dublin West 161 (7.9) 103 (5.1) 99 (4.7) 106 (5.9) 79 (4.0) 90 (4.0)
North West Dublin 102 (5.0) 108 (5.4) 104 (5.0) 78 (4.4) 66 (3.3) 91 (4.1)
Dublin North Central 123 (6.1) 79 (3.9) 83 (4.0) 58 (3.2) 111 (5.6) 147 (6.6)
North Dublin 82 (4.0) 71 (3.5) 82 (3.9) 70 (3.9) 87 (4.4) 87 (3.9)
Kildare–West Wicklow 44 (2.2) 32 (1.6) 36 (1.7) 60 (3.4) 68 (3.4) 96 (4.3)
Wicklow East 54 (2.7) 24 (1.2) 28 (1.3) 21 (1.2) 19 (1.0) 26 (1.2)
Kerry 55 (2.7) 58 (2.9) 56 (2.7) 27 (1.5) 42 (2.1) 44 (2.0)
Donegal 32 (1.6) 42 (2.1) 39 (1.9) 63 (3.5) 41 (2.1) 37 (1.7)
Sligo–Leitrim 39 (1.9) 29 (1.4) 36 (1.7) 23 (1.3) 38 (1.9) 31 (1.4)
Longford–Westmeath 43 (2.1) 31 (1.5) 52 (2.5) 42 (2.3) 30 (1.5) 70 (3.1)
Laois–Offaly 31 (1.5) 39 (1.9) 83 (4.0) 65 (3.6) 75 (3.8) 46 (2.1)
Galway 22 (1.1) 54 (2.7) 50 (2.4) 36 (2.0) 58 (2.9) 55 (2.5)
Mayo 21 (1.0) 19 (0.9) 21 (1.0) 13 (0.7) 27 (1.4) 19 (0.9)
Roscommon 3 (0.1) 18 (0.9) 23 (1.1) 10 (0.6) 12 (0.6) 18 (0.8)
Limerick 93 (4.6) 94 (4.7) 68 (3.2) 65 (3.6) 70 (3.5) 108 (4.8)
Clare 21 (1.0) 30 (1.5) 34 (1.6) 27 (1.5) 28 (1.4) 40 (1.8)
North Tipp–East Limerick 17 (0.8) 20 (1.0) 31 (1.5) 20 (1.1) 24 (1.2) 26 (1.2)
Louth 89 (4.4) 66 (3.3) 119 (5.7) 121 (6.8) 115 (5.8) 138 (6.2)
Meath 83 (4.1) 93 (4.6) 92 (4.4) 94 (5.3) 79 (4.0) 111 (5.0)
Cavan–Monaghan 49 (2.4) 27 (1.3) 18 (0.9) 21 (1.2) 30 (1.5) 53 (2.4)
Carlow–Kilkenny 87 (4.3) 119 (5.9) 88 (4.2) 86 (4.8) 108 (5.5) 85 (3.8)
South Tipperary 38 (1.9) 58 (2.9) 109 (5.2) 66 (3.7) 55 (2.8) 56 (2.5)
Wexford 26 (1.3) 57 (2.8) 92 (4.4) 90 (5.0) 126 (6.4) 133 (6.0)
Waterford 71 (3.5) 77 (3.8) 112 (5.3) 105 (5.9) 131 (6.6) 118 (5.3)
Cork† 353 (17.4) 366 (18.3) 317 (15.1) 229 (12.8) 275 (13.9) 286 (12.8)
LHO area unknown‡ 11 (0.5) 17 15 (0.7) 7 (0.4) 5 (0.3) 5 (0.2)
Treatment status 
unknown
179 222 119 161 141 182
*Excludes cases whose HSE region of residence is not known and cases not normally resident in Ireland.
† The LHO area coding for County Cork was inconsistent for the period 2001–2006.
‡ Refers to cases living in Wicklow who were not assigned a specific electoral division code and to cases living in other counties who 
were not assigned a specific county code; it is not possible to assign such cases to an LHO area of residence.
Table 6 Number (%) of cases entered treatment in Ireland, by local health office (LHO) area of 
residence and by treatment status, reported to the NDTRS, 2001 to 2006 (continued)
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Incidence and prevalence of treated drug use
In order to adjust for variation in population size by geographical area, the actual incidence of treated drug 
use in each area was calculated using the average number of new cases over the six-year period living in 
each of the 10 former health board areas, 26 counties and 32 local health office areas; this average was 
divided by the population aged 15–64 years living in the respective former health board areas and counties, 
using the census figures for 2001 and 2006, and for local health office areas using census figures for 2006 
only (Census 2007). 
Between 2001 and 2006, the average incidence of new cases treated for problem drug use was highest in 
the former South Eastern Health Board area (at 117 cases per 100,000 of the 15–64-year-old population), 
followed by the North Eastern (at 91 cases) and Southern (at 84 cases) health board areas (Figure 1). 
Figure 1 Average annual incidence of treated problem drug use among 15–64-year-olds living in 
Ireland, by former health board area of residence, based on returns to the NDTRS per 
100,000 of the population, 2001 to 2006 (Central Statistics Office 2007)
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The Western Health Board area had the lowest incidence, at 29 cases per 100,000, indicating one or more 
of the following: lower drug use rates in this area than in the rest of Ireland, or lower access to or uptake of 
appropriate treatment services.
The incidence of treated problem drug use was examined by county for the period 2001 to 2006 (Figure 
2). The average incidence for the period were highest in Carlow, Waterford, Louth and Wexford (with over 
104 cases per 100,000 of the 15–64-year-old population) followed by Cork, Meath, Tipperary, Kilkenny, 
Sligo, Dublin, and Laois (with between 69 and 93 cases per 100,000). The incidence was lowest in Leitrim, 
Mayo, Galway and Monaghan (with between 11 and 31 cases per 100,000).
Figure 2 Average annual incidence of treated problem drug use among 15–64-year-olds living in 
Ireland, by county, based on returns to the NDTRS per 100,000 of the population, 2001 
to 2006 (Central Statistics Office 2007)
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The average incidence (new cases) of treated problem drug use was examined by local health office area 
for the period 2001 to 2006 (Figure 3). The incidence was highest in Louth, Waterford, Carlow–Kilkenny, 
Dublin West and South Tipperary (with over 103 cases per 100,000 of the 15–64-year-old population) 
followed by Wexford, Cork, Meath, Dublin City North Central, Dublin South West, Dublin South City and 
North West Dublin (with between 67 and 97 cases). The incidence was lowest in Mayo, Galway and North 
Tipperary–East Limerick (with between 24 and 33 cases).
Figure 3 Average annual incidence of treated problem drug use among 15–64-year-olds living in 
Ireland, based on returns to the NDTRS, 2001 to 2006, by local health office area, per 
100,000 of the 2006 population (Central Statistics Office 2007)
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Figure 4 presents the average incidence (new cases) and prevalence (all cases) of treated problem drug use 
from 2001 to 2006 among 15–64-year-olds living in Ireland, expressed per 100,000 of the population. The 
prevalence increased by 15%, from 372 in 2001 to 426 in 2006. This indicates that problem drug use is 
a chronic health condition that requires repeated episodes of treatment over time or continued treatment 
for an extended period of time. The incidence of treated problem drug use among 15–64-year-olds living 
in Ireland decreased marginally (by 4%) in 2002 (72.7 cases per 100,000) when compared to 2001 (75.7 
cases). There was a 15% decrease (to 62 cases) between 2002 and 2004, and a return to the 2001 rate in 
2006 (74.8). The fluctuation in incidence observed during the period masks separate trends in the former 
health board areas. New cases entering treatment are an indirect indicator of recent trends in problem 
drug use.
Figure 4 Incidence and prevalence of treated problem drug use among 15–64-year-olds living and 
treated in Ireland, based on returns to the NDTRS and the CTL per 100,000 population, 
2001 to 2006 (Central Statistics Office 2007) 
Main and additional problem drugs
In 2006, the highest number of cases entering treatment reported opiates as their main problem drug, 
followed by cannabis and then cocaine (Table 7). Overall, the number of cases reporting cannabis as their 
main problem drug decreased in the six-year period. This contrasts with the results of the surveys on drug 
use in the general population, in which cannabis was the most commonly used drug and opiates were 
among the less commonly used drugs reported by respondents (NACD and DAIRU 2005, 2008). General 
population surveys are not an appropriate way to measure problem drug use or drug use in marginalised 
populations, such as those of opiate or crack cocaine users. Research on the use of hard drugs among 
marginalised populations requires special study methods. In line with the results of the 2006/7 general 
population survey, the total number of cases entering treatment who reported cocaine as their main 
problem drug increased considerably (by 581%) between 2001 and 2006. The total number of cases 
entering treatment and reporting ecstasy as their main problem drug decreased by 66% during the 
reporting period. 
The most common main problem drug reported by previously treated cases entering treatment was opiates 
(81%), followed by cannabis (11%) and cocaine (4%).
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The most common main problem drug reported by new cases entering treatment was cannabis (41%), 
followed by opiates (39%) and cocaine (9%). The number of new cases entering treatment who reported 
cocaine as their main problem drug increased sharply (by 695%), from 43 in 2001 to 342 in 2006.
Table 7 Main problem drug used by cases living and entered treatment in Ireland, by treatment 
status, reported to the NDTRS, 2001 to 2006
Main problem drug 2001 2002 2003 2004 2005 2006
Number (%)
All cases entering 
treatment*
4797 4948 5054 4506 4877 5191
Opiates 3109 (64.8) 3075 (62.1) 3029 (59.9) 2863 (63.5) 3094 (63.4) 3280 (63.2)
Ecstasy 282 (5.9) 216 (4.4) 219 (4.3) 139 (3.1) 124 (2.5) 95 (1.8)
Cocaine 81 (1.7) 128 (2.6) 253 (5.0) 331 (7.3) 467 (9.6) 552 (10.6)
Amphetamines 15 (0.3) 25 (0.5) 35 (0.7) 23 (0.5) 36 (0.7) 30 (0.6)
Benzodiazepines 82 (1.7) 79 (1.6) 76 (1.5) 103 (2.3) 75 (1.5) 96 (1.8)
Volatile inhalants 38 (0.8) 43 (0.9) 24 (0.5) 31 (0.7) 27 (0.6) 23 (0.4)
Cannabis 1136 (23.7) 1336 (27.0) 1384 (27.4) 991 (22.0) 1039 (21.3) 1096 (21.1)
Others 54 (1.1) 46 (0.9) 34 (0.7) 25 (0.6) 15 (0.3) 19 (0.4)
Previously treated cases* 2588 2721 2838 2555 2760 2781
Opiates 2107 (81.4) 2180 (80.1) 2190 (77.2) 2108 (82.5) 2281 (82.6) 2237 (80.4)
Ecstasy 80 (3.1) 48 (1.8) 69 (2.4) 33 (1.3) 30 (1.1) 29 (1.0)
Cocaine 31 (1.2) 56 (2.1) 96 (3.4) 119 (4.7) 175 (6.3) 194 (7.0)
Amphetamines 11 (0.4) 10 (0.4) 14 (0.5) 7 (0.3) 14 (0.5) 9 (0.3)
Benzodiazepines 41 (1.6) 53 (1.9) 49 (1.7) 50 (2.0) 30 (1.1) 40 (1.4)
Volatile inhalants 1 (0.0) 6 (0.2) 2 (0.1) 2 (0.1) 5 (0.2) 3 (0.1)
Cannabis 299 (11.6) 349 (12.8) 401 (14.1) 224 (8.8) 219 (7.9) 260 (9.3)
Others 18 (0.7) 19 (0.7) 17 (0.6) 12 (0.5) 6 (0.2) 9 (0.3)
New cases* 2030 2005 2097 1790 1976 2228
Opiates 901 (44.4) 760 (37.9) 759 (36.2) 654 (36.5) 722 (36.5) 912 (40.9)
Ecstasy 197 (9.7) 162 (8.1) 150 (7.2) 103 (5.8) 92 (4.7) 65 (2.9)
Cocaine 43 (2.1) 61 (3.0) 148 (7.1) 195 (10.9) 275 (13.9) 342 (15.4)
Amphetamines 4 (0.2) 15 (0.7) 21 (1.0) 16 (0.9) 22 (1.1) 21 (0.9)
Benzodiazepines 36 (1.8) 26 (1.3) 27 (1.3) 47 (2.6) 42 (2.1) 50 (2.2)
Volatile inhalants 36 (1.8) 36 (1.8) 20 (1.0) 28 (1.6) 21 (1.1) 19 (0.9)
Cannabis 781 (38.5) 924 (46.1) 955 (45.5) 736 (41.1) 794 (40.2) 809 (36.3)
Others 32 (1.6) 21 (1.0) 17 (0.8) 11 (0.6) 8 (0.4) 10 (0.4)
Treatment status 
unknown*
179 222 119 161 141 182
*Excludes cases whose HSE region of residence was not known and cases not normally resident in Ireland.
The main problem drug reported by new cases entering drug treatment between 2001 and 2006 was 
examined by HSE region of residence (Table 8). Cases living in the HSE Dublin North East and Dublin Mid-
Leinster regions reported opiates, while cases living in the HSE South and West regions reported cannabis. 
Across all HSE regions, between 7% and 10% of new cases reported cocaine as their main problem drug, 
which indicates that problem cocaine use is a small but nationwide problem.
An opiate (mainly heroin) was the most common main problem drug reported by new cases who lived in 
Dublin and attended drug treatment (not shown in table). There was a 31% decrease in the number of 
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new opiate cases residing in Dublin and entering treatment, from 675 in 2001 to 468 in 2006, indicating 
that the heroin epidemic in this area has abated. In contrast, there was a 96% increase in the number of 
new opiate cases entering treatment who lived outside Dublin, from 226 in 2001 to 442 in 2006. 
Table 8 Main problem drug used by new cases living and entering treatment in Ireland, by HSE 
region of residence, reported to the NDTRS, 2001 to 2006
Main problem drug Dublin North East Dublin Mid-Leinster South West
Number (%)
New cases* 3033 3210 4131 1752
Opiates 1667 (55.0) 2285 (71.2) 464 (11.2) 292 (16.7)
Ecstasy 103 (3.4) 82 (2.6) 394 (9.5) 190 (10.8)
Cocaine 275 (9.1) 242 (7.5) 405 (9.8) 142 (8.1)
Amphetamines 3 (0.1) 5 (0.2) 68 (1.6) 23 (1.3)
Benzodiazepines 43 (1.4) 39 (1.2) 122 (3.0) 24 (1.4)
Volatile inhalants 15 (0.5) 16 (0.5) 75 (1.8) 54 (3.1)
Cannabis 913 (30.1) 530 (16.5) 2546 (61.6) 1010 (57.6)
Others 14 (0.5) 11 (0.3) 57 (1.4) 17 (1.0)
*Excludes cases whose HSE region of residence was not known and cases not normally resident in Ireland.
The vast majority (71%) of drug cases treated between 2001 and 2006 reported problem use of more than 
one substance (polysubstance use). The proportion of cases entering drug treatment who reported using 
more than one drug increased somewhat up to 2003 but decreased subsequently (Table 9). The same trend 
was noted among new and previously treated cases. Polysubstance use increases the complexity of such 
cases, and is associated with poorer treatment outcomes. 
Table 9 Use of more than one drug by cases living and entering treatment in Ireland, by 
treatment status, reported to the NDTRS, 2001 to 2006
Treatment status 2001 2002 2003 2004 2005 2006
Number (%)
All cases entering 
treatment
4797 4948 5054 4506 4877 5191
All cases who used more 
than one drug
3459 (72.1) 3582 (72.4) 3760 (74.4) 3157 (70.1) 3401 (69.7) 3692 (71.1)
Previously treated cases 2588 2721 2838 2555 2760 2781
Previously treated cases 
who used more than 
one drug
1873 (72.4) 1940 (71.3) 2091 (73.7) 1811 (70.9) 1934 (70.1) 2007 (72.1)
New cases 2030 2005 2097 1790 1976 2228
New cases who used 
more than one drug
1469 (72.4) 1496 (74.6) 1588 (75.7) 1244 (69.5) 1374 (69.5) 1555 (69.8)
Treatment status 
unknown
179 222 119 161 141 182
Between 2001 and 2006, the highest proportions of new cases reporting problem use of more than one 
drug lived in the HSE South and West regions; this may be a result of more accurate recording of drug use 
in these regions, rather than an actual higher rate of polysubstance use (Table 10).
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Table 10 Polysubstance use by new cases living and entering treatment in Ireland, by HSE region of 
residence, reported to the NDTRS, 2001 to 2006
Dublin North East Dublin Mid-Leinster South West
New cases Number (%)
Total 3033 3210 4131 1752
New cases who used more 
than one drug
2010 (66.3) 2134 (66.5) 3290 (79.6) 1292 (73.7)
Of the cases who entered treatment during the period under review, 30% reported problem use of two 
substances, 24% reported problem use of three substances and 18% reported problem use of four or more 
substances (Table 11). Previously treated and new cases showed very similar trends. 
Table 11 Number of problem drugs used by cases living and entered treatment in Ireland, by 
treatment status, reported to the NDTRS, 2001 to 2006
Number of problem 
drugs used
2001 2002 2003 2004 2005 2006
Number (%)
All cases entering 
treatment
4797 4948 5054 4506 4877 5191
One drug 1338 (27.9) 1366 (27.6) 1294 (25.6) 1349 (29.9) 1476 (30.3) 1499 (28.9)
Two drugs 1667 (34.8) 1544 (31.2) 1498 (29.6) 1252 (27.8) 1385 (28.4) 1404 (27.0)
Three drugs 1083 (22.6) 1172 (23.7) 1244 (24.6) 1128 (25.0) 1103 (22.6) 1200 (23.1)
Four drugs 709 (14.8) 866 (17.5) 1018 (20.1) 777 (17.2) 913 (18.7) 1088 (21.0)
Previously treated cases 2588 2721 2838 2555 2760 2781
One drug 715 (27.6) 781 (28.7) 747 (26.3) 744 (29.1) 826 (29.9) 774 (27.8)
Two drugs 859 (33.2) 805 (29.6) 836 (29.5) 699 (27.4) 774 (28.0) 732 (26.3)
Three drugs 606 (23.4) 663 (24.4) 702 (24.7) 679 (26.6) 646 (23.4) 669 (24.1)
Four drugs 408 (15.8) 472 (17.3) 553 (19.5) 433 (16.9) 514 (18.6) 606 (21.8)
New cases 2030 2005 2097 1790 1976 2228
One drug 561 (27.6) 509 (25.4) 509 (24.3) 546 (30.5) 602 (30.5) 673 (30.2)
Two drugs 739 (36.4) 649 (32.4) 636 (30.3) 505 (28.2) 573 (29.0) 625 (28.1)
Three drugs 448 (22.1) 480 (23.9) 516 (24.6) 413 (23.1) 430 (21.8) 479 (21.5)
Four drugs 282 (13.9) 367 (18.3) 436 (20.8) 326 (18.2) 371 (18.8) 451 (20.2)
Treatment status 
unknown
179 222 119 161 141 182
Between 2001 and 2006, a higher proportion of new cases entering drug treatment and living in the HSE 
South Region reported use of third and fourth drugs when compared to other HSE regions (Table 12). 
Table 12 Number of problem drugs used by new cases living and entering treatment in Ireland, by 
HSE region of residence, reported to the NDTRS, 2001 to 2006
Number of problem drugs used Dublin North East Dublin Mid-Leinster South West
Number (%)
New cases 3033 3210 4131 1752
One drug 1023 (33.7) 1076 (33.5) 841 (20.4) 460 (26.3)
Two drugs 919 (30.3) 1002 (31.2) 1220 (29.5) 586 (33.4)
Three drugs 621 (20.5) 665 (20.7) 1085 (26.3) 395 (22.5)
Four drugs 470 (15.5) 467 (14.5) 985 (23.8) 311 (17.8)
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Table 13 Additional problem drugs used by cases living and entered treatment in Ireland, by 
treatment status, reported to the NDTRS, 2001 to 2006
Additional problem drug(s) 
used*
2001 2002 2003 2004 2005 2006
Number (%)
All cases 3459 3582 3760 3157 3401 3692
Cannabis 1383 (40.0) 1362 (38.0) 1445 (38.4) 1239 (39.2) 1417 (41.7) 1579 (42.8)
Alcohol 829 (24.0) 1024 (28.6) 1288 (34.3) 993 (31.5) 1136 (33.4) 1460 (39.5)
Cocaine 624 (18.0) 829 (23.1) 1095 (29.1) 1029 (32.6) 1144 (33.6) 1362 (36.9)
Benzodiazepines 1014 (29.3) 1078 (30.1) 993 (26.4) 859 (27.2) 963 (28.3) 1043 (28.3)
Ecstasy 910 (26.3) 907 (25.3) 968 (25.7) 631 (20.0) 645 (19.0) 597 (16.2)
Opiates 620 (17.9) 735 (20.5) 711 (18.9) 712 (22.6) 686 (20.2) 701 (19.0)
Amphetamines 262 (7.6) 274 (7.6) 326 (8.7) 206 (6.5) 195 (5.7) 205 (5.6)
Others 261 (7.5) 214 (6.0) 172 (4.6) 125 (4.0) 113 (3.3) 98 (2.7)
Volatile inhalants 57 (1.6) 58 (1.6) 41 (1.1) 45 (1.4) 31 (0.9) 23 (0.6)
Not recorded† 0 (0.0) 5 (0.1) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Previously treated cases 1873 1940 2091 1811 1934 2007
Cannabis 797 (42.6) 797 (41.1) 842 (40.3) 757 (41.8) 844 (43.6) 925 (46.1)
Benzodiazepines 779 (41.6) 817 (42.1) 778 (37.2) 668 (36.9) 739 (38.2) 765 (38.1)
Cocaine 377 (20.1) 490 (25.3) 650 (31.1) 648 (35.8) 717 (37.1) 827 (41.2)
Opiates 438 (23.4) 525 (27.1) 489 (23.4) 569 (31.4) 515 (26.6) 463 (23.1)
Alcohol 319 (17.0) 374 (19.3) 557 (26.6) 357 (19.7) 439 (22.7) 576 (28.7)
Ecstasy 355 (19.0) 327 (16.9) 367 (17.6) 214 (11.8) 223 (11.5) 197 (9.8)
Amphetamines 84 (4.5) 100 (5.2) 120 (5.7) 66 (3.6) 69 (3.6) 88 (4.4)
Others 128 (6.8) 97 (5.0) 81 (3.9) 65 (3.6) 53 (2.7) 38 (1.9)
Volatile inhalants 18 (1.0) 18 (.9) 14 (.7) 12 (.7) 9 (.5) 9 (.4)
Not recorded† 0 (0.0) 2 (0.1) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
New cases 1469 1496 1588 1244 1374 1555
Alcohol 499 (34.0) 617 (41.2) 707 (44.5) 599 (48.2) 663 (48.3) 846 (54.4)
Cannabis 540 (36.8) 511 (34.2) 556 (35.0) 449 (36.1) 527 (38.4) 583 (37.5)
Ecstasy 518 (35.3) 547 (36.6) 584 (36.8) 401 (32.2) 407 (29.6) 394 (25.3)
Cocaine 223 (15.2) 304 (20.3) 421 (26.5) 355 (28.5) 401 (29.2) 477 (30.7)
Benzodiazepines 213 (14.5) 230 (15.4) 191 (12.0) 161 (12.9) 198 (14.4) 257 (16.5)
Opiates 162 (11.0) 190 (12.7) 198 (12.5) 123 (9.9) 150 (10.9) 194 (12.5)
Amphetamines 171 (11.6) 168 (11.2) 205 (12.9) 138 (11.1) 123 (9.0) 113 (7.3)
Others 117 (8.0) 101 (6.8) 87 (5.5) 52 (4.2) 57 (4.1) 58 (3.7)
Volatile inhalants 38 (2.6) 39 (2.6) 27 (1.7) 31 (2.5) 20 (1.5) 14 (0.9)
Not recorded† 0 (0.0) 3 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Treatment status unknown 117 146 81 102 93 130
*By cases reporting use of one, two or three additional drugs.
† The type of additional problem drug was not specified. 
Table 13 shows the additional problem drugs used by those reporting problem use of more than one drug, 
by treatment status. Between 2001 and 2006, cannabis, alcohol, cocaine and benzodiazepines were the 
most common additional problem drugs reported by all cases entering treatment. Cannabis was top of 
this list in each of the six years ,and its use as an additional substance increased by 14% over the reporting 
period. Benzodiazepines were the second most common additional drug in 2001 and 2002, replaced by 
alcohol in 2003 and in 2006 and by cocaine in 2004 and 2005. Between 2001 and 2006, the total number 
of cases entering treatment and reporting alcohol or cocaine as an additional problem drug increased by 
76% and 118%, respectively.
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The most frequently used additional problem drugs reported by previously treated cases in the period 
under review were cannabis, benzodiazepines, cocaine and opiates. Cannabis and benzodiazepines ranked 
as the top two additional drugs for previously treated cases entering treatment up to 2005, and in 2006 
cocaine replaced benzodiazepines as the second most common additional drug. The percentage rise in 
cocaine as an additional problem drug was similar among previously treated cases (at 119%) to that among 
all cases (at 118%). 
New cases entering treatment reported alcohol, cannabis, ecstasy and cocaine as the most commonly used 
additional problem drugs. From 2002 to 2003 alcohol and ecstasy were ranked as the two most common 
additional problem drugs, but in 2004 cannabis replaced ecstasy as the second most common additional 
problem drug. The use of alcohol and cocaine as additional problem drugs by new cases rose by 70% and 
114% respectively over the period under review. 
In the HSE South and West regions the two most common additional problem drugs reported by new cases 
were alcohol and ecstasy, while cannabis and cocaine were the two most common additional problem 
drugs reported by new cases in the HSE Dublin North East and HSE Dublin Mid–Leinster regions (Table 14).
Table 14 Additional problem drugs used by new cases living and entering treatment in Ireland, by 
HSE region of residence, reported to the NDTRS, 2001 to 2006
Additional problem drug(s) 
used
Dublin North East Dublin Mid-Leinster South West
Number (%)
New cases who used 
additional drug(s)
2010 2134 3290 1292
Alcohol 452 (22.5) 496 (23.2) 2231 (67.8) 752 (58.2)
Cannabis 888 (44.2) 1054 (49.4) 852 (25.9) 372 (28.8)
Ecstasy 506 (25.2) 430 (20.1) 1415 (43.0) 500 (38.7)
Cocaine 557 (27.7) 592 (27.7) 742 (22.6) 290 (22.4)
Benzodiazepines 488 (24.3) 516 (24.2) 174 (5.3) 72 (5.6)
Opiates 355 (17.7) 464 (21.7) 142 (4.3) 56 (4.3)
Amphetamines 171 (8.5) 95 (4.5) 514 (15.6) 138 (10.7)
Volatile inhalants 39 (1.9) 23 (1.1) 54 (1.6) 53 (4.1)
Others 113 (5.6) 62 (2.9) 221 (6.8) 76 (5.9)
Not recorded† 2 (0.1) 1 (0.0) 0 (0.0) 0 (0.0)
*By new cases reporting use of one, two or three additional drugs.
† The type of additional problem drug was not specified.
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The association between main problem drug and additional drugs among new cases entering treatment 
was examined for the period 2001 to 2006 (Table 15). The pattern of additional drugs used was linked 
to the main problem drug. For example, where an opiate was the main problem drug the most common 
additional problem drugs were cannabis (40%), followed by cocaine (22%) and benzodiazepines (22%), 
whereas where cannabis was the main problem drug the most common additional drugs were alcohol 
(48%), followed by ecstasy (38%) and cocaine (17%). Where cocaine was the main problem drug, 
the most common additional problem drugs were cannabis (57%), alcohol (47%) and ecstasy (37%). 
Information about the combinations of drugs used is important in terms of individual clients’ care plans, 
and policy initiatives. The proportion of new cases reporting alcohol as an additional problem substance 
was relatively high (between 36% and 48%) except in cases reporting an opiate as their main problem 
drug. These data indicate a link between alcohol and illicit drug use. 
Table 15 Main problem drug and associated additional drugs used by new cases living and entering 
treatment in Ireland and reported to the NDTRS, 2001 to 2006
New cases 4708 769 1064 99 228 160 4999
Main problem drug
Opiates Ecstasy Cocaine
Amphet-
amines
Benzo-
diazepines
Volatile 
inhalants
Cannabis
Additional problem 
drug(s) used*
Number (%)
Opiates 751 (16.0)† 16 (2.1) 78 (7.3) 1 (1.0) 36 (15.8) 2 (1.3) 128 (2.6)
Ecstasy 447 (9.5) 394 (37.0) 49 (49.5) 32 (14.0) 11 (6.9) 1897 (37.9)
Cocaine 1029 (21.9) 206 (26.8) 12 (1.1)† 25 (25.3) 37 (16.2) 3 (1.9) 865 (17.3)
Amphetamines 89 (1.9) 183 (23.8) 109 (10.2) 4 (1.8) 2 (1.3) 528 (10.6)
Benzodiazepines 1029 (21.9) 20 (2.6) 67 (6.3) 2 (2.0) 9 (3.9)† 1 (0.6) 117 (2.3)
Volatile inhalants 17 (0.4) 15 (2.0) 5 (0.5) 1 (1.0) 3 (1.3) 8 (5.0)† 118 (2.4)
Cannabis 1866 (39.6) 489 (63.6) 611 (57.4) 60 (60.6) 56 (24.6) 47 (29.4) 6 (0.1)†
Alcohol 466 (9.9) 341 (44.3) 497 (46.7) 36 (36.4) 103 (45.2) 57 (35.6) 2389 (47.8)
*By cases reporting use of one, two or three additional drugs.
† Additional problem drug(s) used may be a form of drug in the same family as the main problem drug.
Treatment provision
Of the 5,191 cases entering treatment for problem drug use in 2006, 51% received counselling, 39% 
received methadone substitution, 17% received a brief intervention and 14% attended medication-free 
therapy (Figure 5). Thirty-six per cent of cases received more than one initial treatment intervention 
(Figure 6). It is widely recognised that no single intervention will effectively treat problem drug use. It is 
important to note that the NDTRS form records only the initial treatment provided in each case. Treatment 
interventions that may be provided subsequently are not recorded. In recent years there has been an 
increase in the types of intervention provided and a greater emphasis on brief intervention, counselling, 
family therapy, aftercare and social re-integration. With the help of regional and local drugs task forces, a 
number of community and voluntary organisations have been set up throughout the country in response to 
specific problem drugs, such as alcohol, cocaine or opiates, used in local areas.
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Figure 5 Percentage of cases living and entering treatment in Ireland who availed of each type of 
initial treatment intervention provided, reported to the NDTRS, 2006
Figure 6 Percentage of cases living and entering treatment in Ireland, by the number of treatment 
interventions availed of, reported to the NDTRS, 2006
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Risk behaviours
Between 2001 and 2006, the median age at which all cases entering treatment commenced their drug use 
ranged between 14 and 15 years (Table 16), which indicates that at least half of treated drug users had 
commenced drug use before they were 15 years old. Of all cases who reported ever having injected illicit 
(or licit) drugs, 50% started injecting before they were 19 years old. The median age at which previously 
treated cases started injecting was 19 years, whereas the median age at which new cases started injecting 
ranged between 19 and 21 years. This is a little older than previously reported and indicates an increasing 
interval between commencing illicit drug use and moving on to injecting drug use. 
Table 16 Risk behaviours reported by all cases living and entering treatment in Ireland, by 
treatment status, reported to the NDTRS, 2001 to 2006
2001 2002 2003 2004 2005 2006
All cases 4643 4748 4924 4356 4707 4992
Number (%) who had
ever injected
2216 (47.7) 2242 (47.2) 2233 (45.3) 2074 (47.6) 2164 (46.0) 2104 (42.1)
Of whom:†
Ever shared 1404 (63.4) 1386 (61.8) 1378 (61.7) 1245 (60.0) 1305 (60.3) 1239 (58.9)
Currently injecting 1142 (51.5) 1008 (45.0) 1000 (44.8) 990 (47.7) 918 (42.4) 954 (45.3)
Median age (range*) 
started drug use, in years
15 (11–22) 15 (11–22) 14 (11–21) 14 (11–21) 15 (11–23) 14 (11–22)
Median age (range*) 
started injecting, in years
19 (15–29) 19 (15–30) 19 (15–29) 19 (15–29) 19 (14–30) 19 (15–30)
Previously treated cases 2505 2609 2747 2448 2639 2660
Number (%) who had
ever injected
1657 (66.1) 1760 (67.5) 1722 (62.7) 1679 (68.6) 1745 (66.1) 1595 (60.0)
Of whom:†
Ever shared 1133 (68.4) 1164 (66.1) 1147 (66.6) 1064 (63.4) 1112 (63.7) 1012 (63.4)
Currently injecting 810 (48.9) 744 (42.3) 687 (39.9) 739 (44.0) 704 (40.3) 707 (44.3)
Median age (range*) 
started drug use, in years
15 (11–21) 14 (11–21) 14 (11–20) 14 (11–21) 14 (11–21) 14 (11–21)
Median age (range*) 
started injecting, in years
19 (14–28) 19 (15–29) 19 (15–28) 19 (15–29) 19 (14–30) 19 (15–29)
New cases 1989 1954 2075 1770 1940 2173
Number (%) who had
ever injected
489 (24.6) 409 (20.9) 461 (22.2) 333 (18.8) 358 (18.5) 423 (19.5)
Of whom:†
Ever shared 248 (50.7) 195 (47.7) 214 (46.4) 152 (45.6) 160 (44.7) 188 (44.4)
Currently injecting 287 (58.7) 228 (55.7) 298 (64.6) 213 (64.0) 189 (52.8) 215 (50.8)
Median age (range*) 
started drug use, in years
15 (12–23) 15 (11–23) 15 (12–22) 15 (11–21) 15 (11–24) 15 (12–24)
Median age (range*) 
started injecting, in years
19 (15–32) 20 (15–34) 20 (15–31) 21 (15–34) 20 (15–31) 20 (15–32)
Treatment status 
unknown
149 185 102 138 128 159
*Age range presented is the 5th to 95th percentile (90% of cases are included within this range).
† It is not possible to ascertain the exact percentage of injectors with each risk factor of interest as not all known injectors provided the 
relevant information.
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The total number of injector cases who were still injecting at entry to treatment decreased noticeably (by 
20%), from 1,142 in 2001 to 918 in 2005, and a marginal (4%) increase was noted between 2005 and 
2006. A somewhat similar trend was noted for previously treated cases. In total, 2,473 new injector cases 
entered treatment between 2001 and 2006, over half of whom were still injecting on entry to treatment. 
In the six-year period, the proportion of new cases who reported injecting at entry to treatment was higher 
than that of previously treated cases. 
As expected, a higher proportion of previously treated injector cases (65%) reported sharing injecting 
equipment than the proportion of new injector cases (47%). Overall, the proportion of injector cases who 
reported sharing equipment decreased between 2001 and 2006. Several studies in Ireland have linked 
injecting drug use with infection by blood-borne viruses such as hepatitis C and HIV (Long 2006). 
Between 2001 and 2006, the median age at which new cases commenced illicit use of drugs was 15 years 
across all HSE regions (Table 17). The median age at which new cases commenced injecting drug use was 
lowest in the HSE Dublin Mid-Leinster Region at 19 years and highest in the HSE West Region at 23 years. 
During the period under review, the number of new cases entering treatment who had ever injected drugs 
was much lower in the HSE South and West regions than in the HSE Dublin Mid-Leinster and Dublin North 
Eastern regions.
Table 17 Risk behaviours reported by new cases living and entering treatment in Ireland, by HSE 
region of residence, reported to the NDTRS, 2001 to 2006
Dublin North East Dublin Mid-Leinster South West
New injector cases 2961 3143 4089 1708
Number (%) ever injected 916 (30.9) 1208 (38.4) 231 (5.6) 118 (6.9)
Of whom:†
Ever shared 462 (50.4) 571 (47.3) 87 (37.7) 37 (31.4)
Currently injecting 537 (58.6) 708 (58.6) 131 (56.7) 54 (45.8)
Median age (range*) started 
drug use, in years
15 (12–22) 15 (11–23) 15 (12–23) 15 (12–22)
Median age (range*) started 
injecting, in years
20 (15–33) 19 (15–30) 20 (15–34) 23 (15–34)
*Age range presented is the 5th to 95th percentile (90% of cases are included within this range).
† It is not possible to ascertain the exact percentage of injectors with each risk factor of interest as not all known injectors provided the 
relevant information.
Socio–demographic characteristics
The median age of previously treated cases entering treatment increased from 25 to 28 years between 
2001 and 2006, while the median age of new cases increased by two years, from 22 to 24 years (Table 18). 
Almost 18% of new cases were under 18 years of age, while less than 3% of previously treated cases were 
in this age group. The proportion of new cases under 18 years decreased noticeably in 2006, which may 
reflect under-reporting in HSE Dublin Mid-Leinster and Dublin North East (Table 19). There was an increase 
in the number of male cases entering treatment, most notable among new cases. The proportion of cases 
who reported living with their parents or family was higher among new cases entering treatment than 
among previously treated cases, 62% compared to 51%. Though small, the proportion of cases reporting 
being homeless and the proportion not born in Ireland both increased steadily during the reporting 
period. Previously treated cases entering treatment reported a higher incidence of homelessness (5%) than 
new cases (3%). In 2006, a higher proportion of new cases (4%) than of previously treated cases (3%) 
reported that they were not born in Ireland. The increase in the proportion of other nationalities seeking 
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treatment may have implications for service provision, as these types of interventions rely heavily on verbal 
communication. The proportion of cases who reported leaving school early was higher among previously 
treated cases (23%) than among new cases (15%). The proportion of cases reporting that they were still 
in school on entry to treatment was higher among new cases (12%) than among previously treated cases 
(1%). Overall, 19% of previously treated cases aged 16–64 reported that they were in employment on 
entry to treatment, in comparison to 29% of new cases.
Table 18 Socio–economic characteristics of cases living and entering treatment in Ireland, by 
treatment status, reported to the NDTRS, 2001 to 2006
2001 2002 2003 2004 2005 2006
Characteristics* Number (%)
All cases 4797 4948 5054 4506 4877 5191
Median age (range†) 24 (16–40) 24 (16–40) 25 (16–40) 25 (16–40) 26 (16–41) 27 (17–42)
Under-18s 440 (9.2) 497 (10.0) 526 (10.4) 415 (9.2) 404 (8.3) 363 (7.0)
Males 3516 (73.3) 3552 (71.8) 3577 (70.8) 3291 (73.0) 3613 (74.1) 3983 (76.7)
Living with family 2861 (59.6) 2871 (58.0) 2817 (55.7) 2393 (53.1) 2536 (52.0) 2664 (51.3)
Homeless 153 (3.2) 148 (3.0) 195 (3.9) 197 (4.4) 217 (4.4) 265 (5.1)
Non-Irish nationals 135 (2.8) 135 (2.7) 168 (3.3) 123 (2.7) 162 (3.3) 195 (3.8)
Early school leavers 937 (19.5) 895 (18.1) 974 (19.3) 892 (19.8) 986 (20.2) 1040 (20.0)
Still at school 198 (4.1) 318 (6.4) 377 (7.5) 271 (6.0) 275 (5.6) 222 (4.3)
Employed (aged 16-64) 1240 (26.7) 1125 (23.8) 1080 (22.3) 956 (22.0) 1025 (21.8) 1069 (21.2)
Previously treated cases 2588 2721 2838 2555 2760 2781
Median age (range†) 25 (18–40) 26 (19–42) 26 (19–41) 27 (19–41) 28 (19–42) 28 (19–43)
Under-18s 80 (3.1) 81 (3.0) 86 (3.0) 64 (2.5) 72 (2.6) 72 (2.6)
Males 1882 (72.7) 1892 (69.5) 1953 (68.8) 1782 (69.7) 1972 (71.4) 2093 (75.3)
Living with family 1451 (56.1) 1441 (53.0) 1454 (51.2) 1250 (48.9) 1291 (46.8) 1343 (48.3)
Homeless 86 (3.3) 85 (3.1) 124 (4.4) 136 (5.3) 155 (5.6) 156 (5.6)
Non-Irish nationals 80 (3.1) 63 (2.3) 86 (3.0) 69 (2.7) 74 (2.7) 95 (3.4)
Early school leavers 578 (22.3) 587 (21.6) 617 (21.7) 599 (23.4) 685 (24.8) 660 (23.7)
Still at school 24 (0.9) 37 (1.4) 43 (1.5) 31 (1.2) 29 (1.1) 22 (0.8)
Employed (aged 16-64) 582 (22.7) 555 (20.7) 559 (19.9) 445 (17.5) 460 (16.8) 447 (16.2)
New cases 2030 2005 2097 1790 1976 2228
Median age (range†) 22 (15–37) 22 (15–38) 22) (15–39 22 (15–38) 23 (15–39) 24 (15–40)
Under-18s 351 (17.3) 407 (20.3) 430 (20.5) 338 (18.9) 326 (16.5) 285 (12.8)
Males 1495 (73.6) 1497 (74.7) 1539 (73.4) 1392 (77.8) 1542 (78.0) 1758 (78.9)
Living with family 1344 (66.2) 1322 (65.9) 1323 (63.1) 1065 (59.5) 1175 (59.5) 1227 (55.1)
Homeless 51 (2.5) 48 (2.4) 62 (3.0) 52 (2.9) 54 (2.7) 103 (4.6)
Non-Irish nationals 47 (2.3) 61 (3.0) 78 (3.7) 50 (2.8) 84 (4.3) 93 (4.2)
Early school leavers 333 (16.4) 279 (13.9) 338 (16.1) 264 (14.7) 274 (13.9) 339 (15.2)
Still at school 171 (8.4) 276 (13.8) 325 (15.5) 234 (13.1) 240 (12.1) 196 (8.8)
Employed (aged 16-64) 615 (32.3) 522 (28.4) 501 (26.1) 487 (29.4) 542 (29.7) 590 (28.0)
Treatment status 
unknown
179 222 119 161 141 182
*It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had 
complete data.
† Age range presented is the 5th to 95th percentile (90% of cases are included within this range).
30 HRB Trends Series 2
The socio–economic characteristics of new cases treated were examined by HSE region of residence for the 
reporting period (Table 19). The proportion of new cases who were under 18 years was considerably higher 
in the HSE West and South regions than in the other two HSE regions; this may be due to under-reporting 
in the other two regions or to a lack of appropriate treatment facilities for young drug users. In the HSE 
West and South regions, new cases aged under 18 years were more likely to be in school than they were in 
the other two regions. In the HSE Dublin Mid-Leinster Region a higher proportion had left school early than 
in the Dublin North East Region.
Table 19 Socio–economic characteristics of new cases living and entering treatment in Ireland, by 
HSE region of residence, reported to the NDTRS, 2001 to 2006
Dublin North East Dublin Mid-Leinster South West
Number (%)
New cases* 3033 3210 4131 1752
Median age (range†) in years 23 (15–38) 23 (16–38) 21 (15–39) 21 (15–38)
Under-18s 508 (16.7) 294 (9.2) 892 (21.6) 443 (25.3)
Males 2217 (73.1) 2273 (70.8) 3380 (81.8) 1353 (77.2)
Living with parents/family 1860 (61.3) 1891 (58.9) 2623 (63.5) 1082 (61.8)
Homeless 114 (3.8) 86 (2.7) 129 (3.1) 41 (2.3)
Non-Irish nationals 75 (2.5) 89 (2.8) 166 (4.0) 83 (4.7)
Early school leavers 495 (16.3) 571 (17.8) 560 (13.6) 201
Still at school 328 (10.8) 161 (5.0) 599 (14.5) 354 (20.2)
Employed (16–64-year-olds) 753 (26.8) 817 (26.3) 1271 (33.7) 416 (26.7)
*It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had 
complete data.
† Age range presented is the 5th to 95th percentile (90% of cases are included within this range).
Relationship between main problem drug and selected characteristics
In order to highlight important relationships, the main problem drug reported by new cases entering 
treatment in the period 2001 to 2006 was examined by selected socio-demographic and economic 
characteristics. Figure 7 presents the three most common main problem drugs reported by new cases 
treated in each of the former health board areas. Apart from the North Western and Southern areas, all 
former health board areas reported opiates and cannabis as the two most common main problem drugs 
reported by new cases entering treatment. In the North Western area, cannabis and ecstasy were the 
most common main problem drugs reported by new cases, while the Southern area reported cannabis 
and cocaine. Cocaine was among the three most common main problem drugs in a number of former 
health board areas, including the East Coast Area, South Western Area (of Dublin and Wicklow and 
Kildare), Northern Area (Dublin), North Eastern Area, Southern and Mid-Western. The observations above 
may reflect either the types of drug used or the types of treatment service provided in the area, or a 
combination of both factors. 
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Figure 7 The three most common main problem drugs, by former health board area, for new cases 
living and entering treatment in Ireland, reported to the NDTRS, 2001 to 2006
Figures 8a and 8b present the ages at which new cases living and entering treatment in Ireland between 
2001 and 2006 commenced use of their main problem drug. A considerable number of new cases 
commenced use of cannabis, opiates and, to a lesser extent, volatile inhalants as their main problem drug in 
their early teens. The majority commenced use of cocaine and ecstasy in their mid to late teens. The number 
reporting benzodiazepines as their main problem drug was small; this drug is more commonly reported as 
an additional problem drug by new cases (and by previously treated cases, as shown in Table 13). 
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Figure 8a Age at first use of main problem drug by new cases living and entering treatment in 
Ireland, reported to the NDTRS, 2001 to 2006 
Figure 8b Age at first use of main problem drug (excluding opiates and cannabis) by new cases 
living and entering treatment in Ireland, reported to the NDTRS, 2001 to 2006
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Figures 9a and 9b present the ages at which new cases sought treatment in Ireland, by the main problem 
drug, for the period 2001 to 2006. Although the numbers using volatile inhalants are small, this is the main 
problem substance for a very young client group. It is clear that cannabis and ecstasy users seek treatment 
in their late teens, while the majority of opiate and cocaine users seek treatment in their early twenties. 
Taken together, Figures 8a and 8b and Figures 9a and 9b show the interval between initiation of the main 
problem drug (such as cannabis and opiates) and seeking treatment for problem drug use. 
Figure 9a Age attended first treatment, by main problem drug, for new cases living and entering 
treatment in Ireland, reported to the NDTRS, 2001 to 2006 
Figure 9b Age attended first treatment, by main problem drug (excluding opiates and cannabis), for 
new cases living and entering treatment in Ireland, reported to the NDTRS, 2001 to 2006 
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Figure 10 shows the main problem drug, by gender, for new cases entering treatment in the period 2001 
to 2006. The differences between the proportions of males and females treated were less pronounced in 
the case of volatile inhalants and benzodiazepines than in the case of other drugs.
Figure 10 Main problem drug, by gender, for new cases living and entering treatment in Ireland, 
reported to the NDTRS, 2001 to 2006 
Figure 11 presents the proportion of new cases in employment upon entry to treatment, by the main 
problem drug, for the period 2001 to 2006. The highest rates of employment were among those who used 
drugs commonly associated with social events, and the lower rates were among those who used opiates 
and benzodiazepines. This has important implications for prevention opportunities with young drug users 
and for the social and occupational reintegration of opiate and benzodiazepine users. 
Figure 11 Main problem drug for new cases aged 16–64 years in employment and living and 
entering treatment in Ireland, reported to the NDTRS, 2001 to 2006 
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Figure 12 presents the route of administration of the main problem drug reported by new cases who 
entered treatment between 2001 and 2006. Injecting drug use was associated with opiates and, to a 
lesser extent, with cocaine and amphetamines. The routes of administration shown in Figure 12 are those 
associated with the main problem drugs only. Benzodiazepines are not normally injected as a main problem 
drug, but can be injected by opiate users when used as an additional problem drug.
Figure 12 Route of administration of selected main problem drugs for new cases living and entering 
treatment in Ireland, reported to the NDTRS, 2001 to 2006
Conclusions
Information about people treated for problem drug use, and about patterns of drug use, is valuable in that 
it allows health care managers to describe the extent of the problem, the personal and substance-using 
characteristics of those seeking treatment, and trends in treatment seeking over time. The data presented 
here will enable planners to rank problem drug use alongside other public-health priorities in the population 
and to allocate appropriate resources to its treatment. 
The data presented in this paper indicate that there were significant increases in drug treatment services 
and the total number of people requiring such services since the beginning of the current National Drugs 
Strategy in 2001. The total number of cases treated in 2006 increased by 26% when compared to the 
number treated in 2001. Just over 2,300 methadone places have been created and there was a 25% 
increase in the number of outpatient treatment services during the reporting period. 
Between 2001 and 2006 problematic drug use has become a nationwide issue rather than a predominately 
Dublin issue. In 2006, there were treated drug users living in every county in Ireland. Cannabis was 
reported as a main problem drug by 41% of new cases, opiates by 39% and cocaine by 9%. The number 
of new opiate cases attending treatment decreased noticeably in Dublin while the number increased 
substantially outside Dublin. Across all HSE regions, between 7% and 10% of new cases reported cocaine as 
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their main problem drug and the trend in treated cocaine use was in line with the reported use of cocaine 
among the general population (NACD, 2008). 
The vast majority (72%) of new cases treated between 2001 and 2006 reported problem use of more 
than one substance (polysubstance use) and this is a major challenge facing drug services. The two most 
common additional problem drugs reported by new cases were alcohol and ecstasy in the HSE South and 
West regions, and cannabis and cocaine in the HSE Dublin North East and Dublin Mid-Leinster regions. The 
association between the main problem drug and additional drugs among new cases entering treatment 
was examined for the period 2001 to 2006. The pattern of additional drugs used was linked to the main 
problem drug. The additional substances used with cannabis and cocaine indicate their link with alcohol 
and other recreational drugs. Information about the combinations of drugs used and the situation in which 
they are used is important in terms of individual clients’ care plans, and policy initiatives.
In general, problem drug users are young and male, have low levels of education, are unlikely to be 
employed, and have no stable homes, indicating the importance of accommodation, personal development 
and educational and employment opportunities as part of the drug treatment and reintegration process. 
These findings are supported by the report of the Working Group on Drugs Rehabilitation (2007); it is 
essential that the recommendations made in this report are implemented. 
Though small, the proportions of treated cases who were not born in Ireland increased steadily during 
the reporting period. The increase in the proportion of other nationalities seeking treatment may have 
implications for service provision as drug treatment interventions rely heavily on verbal communication.
In 2004, there was a decrease in returns to the NDTRS in many areas of the country because of a change 
in the data-collection protocol and a lack of clarity about how the new protocol was to be applied at each 
treatment service. Completion of NDTRS forms or Dublin Addiction Information System (DAIS) entries by 
counsellors working in drug treatment centres in Dublin is sporadic and lower than desired. NDTRS returns 
were not completed by some services in the former Mid-Western Health Board area between 2002 and 
2005, but this was rectified in 2006 and 2007. While there has been an improvement in NDTRS returns 
by general practitioners; further work is required to sustain this improvement and increase coverage. The 
proportion of new cases aged under 18 years was considerably higher in the HSE West and South regions 
than in the other two HSE regions; this may be due to under-reporting in the other two HSE regions or 
to a lack of appropriate treatment facilities for young drug users in those regions. The issues raised in this 
paragraph should be kept in mind when interpreting this paper.
It is important to note that the data recorded by the NDTRS relates to episodes of treatment, rather than 
to individual people treated each year. This means that individuals may appear in the figures more than 
once if they attend more than one treatment service in a year, and may reappear in subsequent years. This 
limits the type of analysis that can be done on the data. The introduction of a unique case identifier as an 
essential element of the NDTRS would be invaluable in determining the precise numbers of people treated 
for problem drug and/or alcohol use and the types of services they attend.
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